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Summary 
Tick-borne pathogens would appear to be vulnerable to vertebrate host immune responses during 
the protracted duration of feeding required by their vectors. However, tick salivary components 
deposited during feeding may inhibit hemostasis and induce immunosuppression. The mode of 
action and the nature of immunosuppressive salivary components remains poorly described. We 
determined that saliva from the main vector of the agent of Lyme disease, Ixodes dammini, profoundly 
inhibited splenic T  cell proliferation in response to stimulation with concanavalin A or phyto- 
hemagglutin, in a dose-dependent manner. In addition, interleukin 2 secretion by the T  cells 
was markedly diminished by saliva. Tick saliva also profoundly suppressed nitric oxide production 
by macrophages stimulated with lipopolysaccharide. Finally, we analyzed the molecular basis 
for the immunosuppressive effects of saliva and discovered that the molecule in saliva responsible 
for our observations was not PGE2, as hypothesized by others, but rather, was a protein of 5,000 
tool wt or higher. 
I 
n contrast to most hematophagous arthropods which feed 
rapidly, ixodid ticks require days to weeks to feed to reple- 
tion (1). This fact would appear to offer at least two obstacles 
to successful blood feeding for ticks. First, ticks must main- 
tain blood flow and prevent blood clotting over this extended 
period. Ticks may circumvent these problems via pharmaco- 
logically active components in their saliva which could aid 
in blood feeding (2, 3, and reviewed in 4). For example, the 
saliva of Ixodes dammini, the tick vector of the agent of Lyme 
disease, contains apyrase, PGE2, and prostacyclin which may 
prevent hemostasis and inflammation such that blood flow 
is enhanced (2-4). Second, because of the long period of time 
the tick remains attached to the host,  certain hosts  (espe- 
cially  unnatural  ones  [5])  are  successful  in  mounting  a 
nonspecific (neutrophils surrounding the mouthparts of the 
feeding tick [6]) and even a specific (T and B cell [5, 7-9]) 
anti-tick immune response.  In fact, this immune response 
can be directed against components of the salivary gland it- 
self (7,  10).  This anti-tick response can decrease the tick's 
blood-feeding success and ultimately cause rejection of the 
tick. Therefore, in order to maintain feeding success, hard 
ticks  would  appear  to  require  antiinflammatory and  im- 
munosuppressive elements in their salivary armamentarium, 
in addition to antihemostatic and vasodilatory activities. 
The pathogens transmitted by ticks are similarly exposed 
to host inflammatory and immune responses at their site of 
inoculation. The dense cellular infiltrate that can characterize 
the feeding cavity surrounding a tick's mouthparts would 
appear to serve as an effective barrier to the entry of pathogens. 
Yet these pathogens still manage to infect the host and, there- 
fore, the pathogens may also exploit the same salivary phar- 
macological and immunosuppressive activities that ensure 
successful tick feeding. Indeed, L dammini saliva inhibits phago- 
cytosis of the Lyme disease spirochete in vitro (11) which may 
enhance infectivity of the spirochete for the host.  In addi- 
tion, antibody responses to the Lyme disease spirochete occur 
rapidly when animals are infected with the spirochete by needle 
inoculation but  these responses are greatly delayed or are 
nonexistent  in  animals  infected with  similar  numbers  of 
spirochetes delivered by infected ticks (12, 13). This suggests 
that tick saliva modifies the host-specific T and B cell response 
to the Lyme spirochete. However, the immunological mech- 
anisms that underlie these observations remain poorly un- 
derstood. It has been suggested by several authors (2, 3, 14-16) 
that the PGEz present in tick saliva mediates immunosup- 
pression.  Indeed, PGE2 has effects on the immune system at 
several levels including the ability to downregulate the func- 
tions of T  and B cells  (17). 
In an effort to explain how ticks might inhibit the devel- 
opment of effective host immunity to themselves and to the 
pathogens they transmit, we have used a T cell mitogen-driven 
response to screen for immunosuppressive effects of L dam- 
mini saliva. If tick saliva were immunosuppressive, it should 
act in a nonspecific fashion and suppress even a T  cell mito- 
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foundly inhibited the mitogenic response of normal murine 
spleen cells (SC) 1 to the T  cell mitogens Con  A  and PHA 
both with respect to T  cell proliferation and IL-2 secretion. 
In addition,  saliva prevented nitric  oxide (NO)  production 
by macrophages activated with LPS. Finally, the immunosup- 
pressive effect of saliva was not  due  to PGE2,  but  instead, 
was mediated  by a  protein  of 5,000  tool wt  or  higher. 
Materials and Methods 
Animals.  Adult female C57BL/6 and C3H/H mice were ob- 
tained from Taconic Farms (Germantown, NY). Adult female New 
Zealand white rabbits were purchased from Millbrook Farms (Wil- 
mington,  MA). 
Reagents  and Chemicals.  Con  A  was  purchased  from  Miles 
Laboratories, Inc. (Naperville, IL), PHA from Pharmacia (PHA-P; 
Uppsala, Sweden), and LPS (W Escherichia coli 055:B5) from Difco 
Laboratories  (Detroit,  MI).  [3H]methylthymidine ([3H]TdR),  5 
Ci/mmol) was obtained from Amersham Corp. (Arlington Heights, 
IL). PGE2 (P-6532), pilocarpine (P-6503),  trypsin (T-2271), and soy 
bean trypsin inhibitor (SBTI; T-6522) were purchased from Sigma 
Chemical Co.  (St.  Louis,  MO). 
Ticks.  Unfed adult female I. dammini  ticks were collected by 
dragging vegetation on Great Island (West Yarmouth, MA) during 
the fall seasons of 1991 and 1992. To collect saliva, ticks were al- 
lowed to feed for 4-5 d on the ears of rabbits.  Engorging  ticks 
were removed, washed, and 1 #1 of 5% (wt/vol) solution ofpilocar- 
pine in absolute methanol was applied to their dorsum. A finely 
drawn capillary tube was fitted over the mouthparts of each tick, 
which were allowed to salivate over the course of 3 to 5 h within 
a humidified chamber held at 37~  as previously described (18). 
Saliva was pooled, filter sterilized through a 0.22 #m syringe filter 
(8110; Costar Corp., Cambridge, MA), and stored at -70~  until 
used. Each batch of saliva comprised material harvested from 20 
to 30 ticks. 
Salivary glands were dissected from partially fed I. dammini fe- 
male ticks, placed in PBS (one pair of glands/100 #1) and stored 
at  -70~  until used. At this time, the glands were disrupted by 
rapidly freezing-and-thawing five times using a dry ice/ethanol bath 
and a 37~  waterbath.  The lysate was cleared of debris by cen- 
trifugation  (10,000 g, 30 s),  filter sterilized,  and used in assays. 
Con A and Phytohemagglutinin Stimulation of  Spleen Cells.  A sus- 
pension of SC was generated from normal C57BL/6 or C3H mice 
and the SC were seeded into 96-well culture plates (3596;  Costar 
Corp.)  at  2  x  10Sml in  medium consisting  of DME  (19) con- 
taining 2  ￿  10 -s M 2-mercaptoethanol and 0.5% normal mouse 
serum. The cells were then stimulated with Con A  (0.5/zg/ml) 
or PHA (1.0/zg/ml) in the absence or presence of tick saliva (con- 
centrations of saliva stated in the text).  24 h later,  the degree of 
proliferation of the SC was determined by pulsing with 1/~Ci/well 
of [3H]TdR for 18 h  followed by scintillation counting. 
Interteukin-2 Production by Spleen Cells and Assays for tnterleukin-2. 
SC were seeded into 24-well culture plates (3424;  Costar Corp.) 
at 5  x  106/ml in DME as described above. The cells were stimu- 
lated with Con A (0.5 #g/ml) in the presence or absence of/. dam- 
mini saliva for 24 h and the supernatants of the cultures were har- 
vested and assayed for the presence of IL-2. 
1 Abbreviations used in this paper: NO, nitric oxide; SBTI, soy bean trypsin 
inhibitor; SC, spleen cells. 
II.-2 was measured in supernatants by a bioassay which used the 
IL-2-dependent indicator cell line, CTLL-2, and by an IL-2-specific 
ELISA. The CTLL assay has been described in detail elsewhere (20). 
Briefly, CTLL cells were maintained in recombinant human IL-2 
(Cetus Corp., Emeryville, CA). The effect of a sample supernatant 
on the proliferation of CTLL was assessed by [3H]TdR incorpo- 
ration followed by scintillation counting. Units/ml of Ib2 in the 
test supernatant were calculated from a standard curve obtained 
with recombinant murine I1+-2 (Genzyme Corp., Cambridge, MA). 
Specificity  was assessed using blocking anti-IL-2  mAb $4B6. 
The IL-2-specific ELISA was developed using mAb's purchased 
from Pharmingen (San Diego, CA). A rat antimurine IL-2 mAb 
(rat IgGz,; 18161D) was used to capture IL-2 and a biotinylated 
rat antimurine IL-2 mAb (rat IgG2s; 18172D) was used as the de- 
tection mAb. The assay was conducted using manufacturer's direc- 
tions and was developed using avidin peroxidase/TMB as the en- 
zymeAubstrate pair.  Units/ml of IL-2 in  test supernatants  were 
calculated by comparison to a standard curve generated with recom- 
binant  murine IL-2. 
NO Production by Macrophages.  C57BL/6  mice were injected 
intraperitoneally with starch as described (21) and 4 d later the cells 
were  harvested  by lavaging  the  peritoneum  with  RPMI  1640 
(GIBCO BRL, Gaithersburg, MD) containing 10% FCS (Hyclone, 
Logan, UT). The cells were plated at 105/0.1 ml in 96-well  cul- 
ture plates. After a 2-h incubation at 37~  nonadherent cells were 
removed by rinsing and the adherent cells were incubated for 2 
h with medium or medium containing L dammini saliva. LPS was 
then added to a final concentration of 10 ng/ml and the levels of 
nitrite in the supernatants of the cultures were assessed at 24 and 
72 h by the Greiss reaction as described (22).  Briefly,  50-#1 cell 
culture supernatants were mixed with 50/xl of Greiss reagent (1% 
sulfanilamide,  0.1%  N-[1-naphthyl]ethyl-enediamine  dihy- 
drochloride [Sigma Chemical Co.] in 2.5% phosphoric acid) and 
incubated at room temperature for 10 rain. Absorbance was mea- 
sured at 570 nm. Concentration of NO2 in the supernatant was 
determined by comparison to a standard curve generated with di- 
lutions  of NaNOz. 
Removing PGEz ~om L dammini Saliva.  To remove PGE2 from 
L  dammini  saliva,  the  saliva was centrifuged in  a  Centricon-3 | 
microconcentrator (Amicon Corp., Beverly, MA). The Centricon-3 
device retains 80-95%  of molecules greater than 5,000 tool wt, 
while allowing 97% of molecules of the tool wt of PGE2 (353) 
to pass through its membrane.  1 ml of DME containing a  1:20 
dilution of saliva and 0.1% normal mouse serum was loaded into 
the upper chamber of the Centricon and centrifuged for 2.5 h at 
5,000 g, 4~  This reduced the volume in the upper chamber to 
50/~1. The filtrate in the lower chamber was saved, 950 ml of fresh 
DME was added to the upper chamber and the Centricon was cen- 
trifuged again at 5,000 g for 2.5 h. In total, this process was repeated 
five times to assure complete removal of the PGE2 from saliva. The 
five filtrates and the retentate were then tested for their content 
of PGE2 (see below) and their ability to inhibit T  cell prolifera- 
tion (see above). 
Enzyme Immunoassayfor PGEz.  To measure PGE2 concentra- 
tions in saliva and fractions thereof, a PGE2 enzyme immunoassay 
kit (sensitivity x<10 pg PGE2/ml) was purchased from Advanced 
Magnetics (Cambridge, MA). The assay was performed following 
manufacturer's directions. 
Digesting I. dammini Saliva with Trypsin.  L dammini saliva was 
mixed with an equal volume of trypsin dissolved  at a concentra- 
tion of 1 mg/ml in 10 mM Tris-HC1 buffer, pH 8.0. The mixture 
was incubated for 30 min at 37~  and the trypsin reaction was 
stopped by adding SBTI dissolved in Tris-HC1 buffer so as to achieve 
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tested for its ability to inhibit Con A-driven T cell proliferation. 
Controls consisted of: (a) trypsin and SBTI incubated together be- 
fore the addition of the saliva to determine whether trypsin or SBTI 
would in any way directly inhibit the actions of saliva; (b) trypsin 
and SBTI incubated together and then added to SC  +  Con A to 
determine whether trypsin or SBTI would in any way influence 
a Con A response. 
Results 
I. dammini Saliva Inhibits T Cell Proliferation to Con A.  To 
test whether tick saliva has immunosuppression effects, normal 
SC from two mouse haplotypes, C57BL/6 (H-2  b) and C3H 
(H-2k), were stimulated in vitro with Con A.  As can be 
seen in Fig.  1, when SC were preincubated for 2 h with dilu- 
tions of I. dammini saliva (1:100 to 1:1,000),  the response of 
the cells to Con A (0.5/zg/ml) was greatly diminished. When 
present at a 1:100 final dilution,  saliva inhibited the mito- 
genic response by 70 to 80%. This inhibition was still evi- 
dent at a 1:1,000 final dilution of I. dammini saliva (inhibi- 
tion ~30%).  Thus, the inhibitory effects of tick saliva are 
dose dependent. In addition, the inhibitory effects of saliva 
were not restricted to one mouse haplotype; substantial inhi- 
bition of the mitogenic response was seen using both C57BL/6 
and C3H SC. Finally, lysates of the salivary glands of female 
I. dammini were also found to suppress the response to Con 
A to an extent similar to that of saliva itself (data not shown). 
The experiment depicted in Fig. 1 is representative of eight 
similar independent experiments. Similar results were obtained 
with other doses of Con A (1.0, 0.25, or 0.1/zg/ml), how- 
ever, the magnitude of proliferation varied with the dose of 
Con A. 
Kinetics of the Response of Spleen Cells to Con A  in the Pres- 
ence of Graded Doses of I. dammini Saliva.  Although I. dam- 
mini saliva markedly inhibited Con A mitogenesis when T 
cell proliferation was assessed by [3H]TdR incorporation at 
24 h of culture (Fig.  1), it was possible that this inhibition 
was not as complete at other times of culture, or that saliva 
simply shifted the kinetics of the response to a later time point. 
These possibilities were addressed in the experiments of Fig. 
2. At 12 and 36 h of culture saliva inhibited the Con A re- 
sponse as much as at 24 h, and saliva did not simply delay 
the response to Con A since the response to Con A was sub- 
siding at 36 h of culture whether the SC were cultured with 
Con A  alone or Con A  +  saliva. In addition, Fig. 2 again 
shows that the inhibition of Con A  mitogenesis is a dose- 
dependent phenomenon: a 1:50 dilution of saliva almost com- 
pletely suppresses  the response, a 1:100 dilution suppresses 
the response by ~80%, and a 1:200 dilution suppresses  50% 
of the response. 
Preincubation of Spleen Cells in L dammini Saliva Is Not Re- 
quired  for lnhibition ofT Cell Proliferation.  In the experiments 
described above, SC were preincubated with I. dammini saliva 
for 2 h before Con A was added to the cultures. However, 
the  experiment depicted in  Fig.  3  demonstrates  that  pre- 
incubation was not necessary; the degree of inhibition of the 
Con A response ("~75%) was identical whether saliva was 
added 2 h in advance of Con A or at the same time as Con A. 
I. dammini Saliva Also Inhibits  T  Cell Proliferation to Phyto- 
hemagglutinin and the Pilocarpine Used to Induce L dammini Sali- 
vation  Is  Not  Responsible for  the  Observed  Immunosuppres- 
sion.  Since Con A is a lectin which binds C~-D-mannose and 
Or-D-glucose, it was possible that I. dammini saliva inhibited 
the Con A  response due to a very large amount of one of 
these sugars in the saliva. To test this possibility, we stimu- 
lated SC with PHA (which binds N-acetylgalactosamine) in 
the presence or absence of I. dammini saliva. Results in Fig. 
4 show that the response to PHA was also markedly inhibited 
by saliva; a 1:100 dilution of saliva inhibited the response to 
PHA (1/~g/ml) by 80%. The experiment depicted in Fig. 
4 is representative of three similar independent experiments. 
Similar results were obtained with other doses of PHA (doses 
as high as 10/~g/ml), however, the magnitude of prolifera- 
tion varied with the dose of PHA. 
It was also possible that I. dammini saliva was inhibiting 
mitogenic responses due to a nonspecific toxic effect of saliva 
for the responding SC. Although this was unlikely since mi- 
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Figure 1.  L  dammini saliva 
inhibits  T  cell proliferation to 
Con A.  SC  from C57BL/6 or 
C3H/H mice  were  placed  into 96- 
well microplates (2  x  105/well) 
and incubated  for 2 h in medium 
alone  or in medium  containing  the 
indicated final dilution of I. dam- 
mini saliva (e.g., 1:100, 1:500, or 
1:I,000). Experimental  wells  were 
then stimulated with Con A (0.5 
/xg/ml); control  wells received  no 
Con A. 24 h later, the wells were 
pulsed with [3H]TdR. 18 h later 
the cultures  were  harvested  and as- 
sessed for T cell proliferation  by 
scintillation  counting. Results are 
presented  as the mean  of triplicate 
cultures +_  SD. 
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Figure  2.  Kinetics of the response of spleen cells to Con A in the pres- 
ence of graded doses of/. datum￿9  saliva. C57BL/6 SC were preincubated 
in medium alone or in the indicated dilutions of L datum￿9  saliva for 2 h. 
Experimental wells were then stimulated with Con A  (0.5/zg/ml); con- 
trol wells received no Con A. At the hours of culture indicated, the cul- 
tures were pulsed with [3H]TdR.  18 h later, the cultures were harvested 
and T  cell proliferation was assessed as in Fig.  1. 
croscopic (inverted phase) observation of SC cultures never 
suggested a direct toxic effect, we routinely directly tested 
the viability of SC (by their ability to exclude trypan blue) 
at the end of culture with either Con A or Con A  +  saliva. 
Using this approach, we never detected a toxic effect of saliva 
for SC. For example, the C57BL/6 SC of Fig.  1 that were 
cultured with Con A for 24 h were 79% viable whereas the 
SC cultured with Con  A  and saliva were 85%  viable. We 
also tested for toxic effects of tick saliva by culturing various 
transformed cell lines in the presence or absence for 24 h and 
pulsing the cells with [3H]TdR to determine whether saliva 
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Figure  3.  Pre-incubation of spleen cells in L datum￿9  saliva is not re- 
quired for inhibition of T cell proliferation. C57BL/6  SC were preincubated 
in medium alone or in a 1:100 dilution of I. datum￿9  saliva for 2 h. The 
SC preincubated in medium alone were then either/eft untreated (nega- 
tive control),  stimulated with Con A  (0.5 #g/ml,  positive control),  or 
treated with a mixture of Con A  and I. datum￿9  saliva (1:100 dilution). 
The SC preincubated in I. datum￿9  saliva were stimulated with Con A 
(0.5/zg/ml).  At 24 h of culture, the cells were pulsed with [3H]TdR, and 
T  cell proliferation was assessed as in Fig.  1. 
Figure  4.  L datum￿9  saliva inhibits T cell proliferation to phytohemag- 
glutinin. C57BL/6 SC were preincubated in medium alone or in a 1:100 
dilution of/. datum￿9  saliva for 2 h. Experimental wells were then stimu- 
lated with PHA (1.0/~g/ml); control wells received no PHA. T cell prolifer- 
ation was assessed as in Fig.  1. 
altered the replicative rate of any of the ceils. We found that 
tick saliva did not alter the degree of proliferation of any of 
the following transformed cell lines (American Type Culture 
Collection, Rocky￿9  MD): EL4 (thymoma, ATCC no. TIB 
39), WEHI 279 (B cell lymphoma, ATCC no CRL 1704), 
P815 (mastocytoma, ATCC no.  TIB 64). 
Finally,  salivation of I. datum￿9  was induced by placing 
1/zl of a 5% (wt/vol) pilocarpine solution in methanol on 
the dorsum (see Materials and Methods).  Since it was pos- 
sible that some of this pilocarpine contaminated the induced 
saliva and might be involved in the suppression ofT cell re￿9 
genesis,  we tested the ability of pilocarpine to inhibit a Con 
A  response.  Pilocarpine in methanol  (5%,  wt/vol),  meth- 
anol alone or saliva were added to SC at dilutions of 1:100 
or greater, and the SC were stimulated with Con A. Results 
in Fig. 5 show that while saliva profoundly inhibited the mito- 
genic response,  neither pilocarpine in methanol  nor meth- 
anol alone had any effect on the response to Con A. 
Taken together, these results suggest that I. dammini saliva 
inhibited T cell responses in a consistent,  nonartifactual  manner 
either via an effect on the T cells themselves and/or via inhi- 
bition of cytokines produced by the cells. 
I. dammini Saliva Inhibits IL-2 Secretion by T  Cells.  Since 
IL-2 is the principal autocrine growth factor for T  cells, L 
datum￿9  saliva could be inhibiting T cell replication through 
its ability to inhibit IL-2 production by the cells. To test this, 
we stimulated SC with  either Con A  alone or Con A  + 
I. dammini saliva and harvested the supernatants of the cul- 
tures 24 h later.  To assess the levels of IL-2 in the test super- 
natants, we first used the IL-2-dependent cell line, CTLL-2. 
Results in Table I  show that saliva markedly inhibited IL-2 
production (77.4%). Since this degree of suppression oflL-2 
production is approximately equal to the degree of suppres- 
sion of T  cell proliferation seen in Fig. 1-5, it is likely that 
L  datum￿9  saliva is inhibiting  T  cell proliferation  through 
its ability to  inhibit  IL-2 production  by the cells. 
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Figure  5.  Pilocarpine/methanol used to induce I. dammini salivation does 
not inhibit T cell proliferation.  C57BL/6 SC were preincubated  2 h in 
either medium alone, methanol at the indicated  final dilutions,  pilocar- 
pine (5% wt/vol in methanol) at the indicated final dilutions,  or/. dam- 
mini saliva at the indicated final dilutions.  The cells were then stimulated 
with Con A (0.5/zg/ml) and T cell proliferation  was assessed as in Fig. 
1. The figure depicts the results of three replicate experiments,  thus,  the 
data were normalized for comparison. Actual proliferative responses ranged 
between 4  x  104 and 8  x  104 cpm. 
Although the results obtained in the CTLL-2 assay system 
showed that I.  dammini  saliva greatly reduced the levels of 
biologically active IL-2 secreted by T cells, this result could 
be due to one of two different mechanisms which the CTLL-2 
assay cannot distinguish between. Either: (a) saliva contains 
an antagonist  for IL-2 such that although IL-2 is secreted 
by T cells, its activity is neutralized by saliva; or (b) saliva 
truly prevents the secretion of IL-2 by T cells. To distinguish 
between these two possibilities and to confirm the results 
Table  1.  I.  dammini Saliva Inhibits IL-2 Secretion by T  Cells 
Units IL-2/ml detected by 
IL-2-specific 
Cell stimulus  CTLL bioassay  ELISA 
Con A  31.0  24.6 
Con A  +  I.  dammini saliva  7.0  4.9 
Normal  C57BL/6  SC  were  placed  into  24-well  macroplates  (5  x 
106/well)  and  incubated  for 2 h in medium alone or in medium con- 
taining a 1:100 final dilution of/. dammini saliva. Experimental wells were 
then stimulated with Con A (0.5/zg/ml); control wells received no Con 
A. 24 h later, the supernatant  of the cultures  was harvested  and assayed 
for IL-2 by the CTLL bioassay or an IL-2-specific  ELISA as described 
in the Materials  and Methods.  In the CTLL bioassay,  an IL-2-specific 
neutralizing  mAb was used to confirm that the proliferation  of the CTLL 
cells was due to genuine IL-2. Control values (SC not stimulated  with 
Con A) have been subtracted from the figures in the Table; control values 
were 1 U  IL-2/ml in the CTLL assay and 0.1 U IL-2/ml in the ELISA 
assay. 
we obtained in the CTLL-2 assay, we used an IL-2-specific 
ELISA. Results with this assay (81.1% suppression) were al- 
most identical to those obtained with the CTLL-2 assay  (Table 
1), which indicated that saliva inhibits  T  cell proliferation 
by inhibiting IL-2 secretion by the cells. 
I. dammini Saliva Inhibits NO Production by Macrophages. Since 
L  dammini saliva profoundly inhibited T cell activation, we 
wished to determine whether it would inhibit activation of 
a different cell type. Macrophages were pre-incubated  with 
saliva for 2 h and stimulated with LPS to induce NO produc- 
tion. NO production was monitored by measuring the levels 
of nitrite released into the supernatants of the cultures. Saliva 
dramatically inhibited NO production by macrophages (Fig. 
6). When present at a 1:100 dilution, saliva completely in- 
hibited NO production (both at 24 and 72 h poststimula- 
tion with LPS); when present at a 1:1,000 dilution, it in- 
hibited NO production by "~50%. Thus, saliva can inhibit 
the functions of T ceils, which are ceils that are central in 
the development of specific  immune responses; and saliva can 
inhibit the functions of macrophages, which are cells that 
play important roles in both specific and nonspecific defense 
mechanisms of the host. 
Ability of Prostaglandin E2 to Mimic the Effects of I. dammini 
Saliva.  Next we attempted to determine the mechanism by 
which saliva inhibits cell activation. We first tested whether 
PGE2 might be responsible for the inhibition by determining 
whether PGE2 could  substitute  for saliva in  the  Con  A 
mitogenic response assay system. Tick saliva was assayed  for 
the level of PGE2 present using the enzyme immunoassay 
for PGE2 described in Materials and Methods and was found 
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I. dammini saliva inhibits nitric oxide production by macro-  Figure  6. 
phages. C57BL/6 macrophages were generated  as described in Materials 
and Methods and were preincubated with the indicated dilutions of/. dam- 
mini saliva for 2 h. Control cells were incubated  in medium alone. After 
2 h, medium  _+  LPS (10 ng/ml) was added to the wells. Aliquots (50 
/~1) of the culture supernatants  were measured for their concentration of 
nitrite at 24 and 72 h after  stimulation  with LPS using techniques  de- 
scribed in Materials and Methods.  Results  are presented  as the mean of 
triplicate  cultures  +  SD. 
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A  in the presence or absence of dilutions  of tick saliva or 
synthetic  PGE2  and  the  ability  of each  to  inhibit  T  cell 
proliferation was determined.  Results in Fig.  7 are plotted 
such that the amount of tick saliva present is given in terms 
of the amount of salivary PGE2 present and not in terms of 
the dilution  of whole saliva.  What  is clear from Fig.  7 is 
that  the PGE2 present in  tick saliva cannot  solely account 
for its  immunosuppressive  effects;  saliva  is  approximately 
1,000-fold more potent  than  synthetic PGE2.  In  addition, 
tick saliva exerts its immunosuppressive  effects over a nar- 
rower range of dilutions  than PGE2; indeed, PGEz did not 
completely inhibit T  cell proliferation even when present at 
1 #g/ml. 
PGE2  in  I.  clammini  Saliva  Plays  a Minor Role  in Its Im- 
munosuppressive  Effects.  To confirm the results of Fig. 7, we 
removed PGE2 from saliva to determine whether this dimin- 
ished its capacity to inhibit  T  cell proliferation.  1 ml of a 
1:20 dilution of I. dammini saliva was loaded into the upper 
chamber of a Centricon-3 |  microconcentrator (see Materials 
and Methods for details of use). The 1:20 dilution of saliva 
contained 108 ng PGEJml. The microconcentrator was cen- 
trifuged until 50/zl remained in the upper chamber, the filtrate 
was  saved,  the fluid in the upper chamber was  replenished 
and this process was repeated for a total of five centrifuga- 
tions. This process completely removed the PGE2 from tick 
saliva.  Filtrate  1 contained 100.0 ng PGE2/ml;  filtrate 2  = 
9.3 ng/ml;  filtrate 3  =  3.3 ng/ml;  filtrate 4  =  0.8 ng/ml; 
filtrate 5  --  0.1 ng/ml;  and the retentate contained 0.03 ng 
PGE2/ml. 
All the filtrates and the retentate were then tested for their 
ability to inhibit T cell proliferation compared to that of whole 
saliva.  Filtrates 2-5 were unable to inhibit T  cell prolifera- 
tion, but filtrate I had some capacity to inhibit proliferation 
and the retentate was as effective as whole saliva in its ability 
to inhibit T  cell proliferation (Fig. 8). Interestingly, the first 
filtrate which contained almost all the PGE2 present in tick 
saliva suppressed T cell proliferation in a manner almost iden- 
tical to synthetic PGEz. The concentrations of salivary PGEz 
are given for three filtrate 1 data points in Fig. 8. When one 
compares Figs.  7 and 8, it can be seen that when present at 
50 ng/ml,  both synthetic and salivary PGE2 suppressed the 
Con  A  response by approximately 30%. 
Taken together,  these results  suggest  that  PGE2 plays a 
minor role in  the immunosuppressive  effects of tick saliva 
and that  a molecule of >5,000  tool wt  (the cut-off of the 
Centricon-3 |  microconcentrator is 5,000-10,000 tool wt) is 
largely responsible for the immunosuppression. 
The Molecule in L dammini Saliva Responsible for Immunosulv- 
pression  Is a Protein.  Since the factor in tick saliva respon- 
sible  for  immunosuppression  was  not  PGE2,  we  tested 
whether the factor was a protein. I. clammini saliva was digested 
with trypsin, the reaction was stopped with SBTI as described 
in Materials and Methods and the product tested for its ability 
to inhibit T cell proliferation. As can be seen in Fig. 9 (group 
D), trypsin digestion destroyed the ability of saliva to inhibit 
T cell proliferation. Importantly, this was not due to the pres- 
ence of trypsin and SBTI in the cultures since control cul- 
tures showed that:  (a) I. dammini saliva was capable of sup- 
pressing a Con A-driven response when it was added after 
the SBTI (Fig. 9, group E); and (b) neither trypsin nor SBTI 
affected the response of SC  to Con  A  (group  C). 
Discussion 
A seminal report by Trager (5) demonstrated that the guinea 
pig,  which  is not  a natural  host  for Dermacenter variabilis, 
mounts a very e~cient immune response to the tick. In ad- 
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Figure 7.  Ability of prostaglandin E2 to mimic the effects of I. dam- 
mini saliva. C57BL/6 SC were preincubated 2 h in either PGE2 at the 
concentrations indicated or L dammini tick saliva diluted so as to achieve 
the indicated concentrations of salivary PGE2. The I. dammini tick saliva 
used in these experiments contained 2.2/zg PGE2/ml (techniques used 
to determine PGE2 concentration given in Materials and Methods). The 
cells were then stimulated with Con A (0.5/zg/ml) and T cell prolifera- 
tion was assessed as in Fig. 1. The figure is representative  of two indepen- 
dent experiments. 
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Figure 8.  PGE2 in I.  dammini saliva plays a minor  role in its im- 
munosuppressive effects. PGE2 was removed from I. dammini saliva by 
repeatedly  centrifuging saliva in a Centricon-3  |  microconcentrator as de- 
scribed in Materials and Methods. The figure depicts the ability of the 
retentate (i.e., molecules in tick saliva that are >5,000 tool wt) and of 
the filtrate (i.e., molecules in saliva that are <5,000 tool wt) to inhibit 
Con A-driven proliferation compared to the inhibition seen with unfrac- 
tionated saliva. Since the filtrate contained  virtually all of the PGE2  present 
in L dammini saliva, the concentrations of salivary PGE2 present in the 
assay are indicated  above  the symbols  for the dilutions of filtrate. The figure 
is representative of three independent experiments. 
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Figure 9.  The molecule in L dammini  saliva responsible  for immunosup- 
pression is a protein. L dammini was digested with trypsin and the reaction 
was stopped by the addition of SBTI (see Materials and Methods). To test 
whether this digested tick saliva  was still capable of mediating immunosup- 
pression, a 1:100 final dilution of the digest was incubated with SC for 
2 h and Con A (0.5 #g/ml) was added to the cultures (group D). Controls 
consisted of SC to which was added trypsin that had already been blocked 
by SBTI followed by the addition of saliva; these cultures  determined 
whether trypsin + SBTI was able to inhibit the immunosuppressive effect 
of saliva  via a mechanism other than proteolysis (group E). The remaining 
control consisted of SC to which was added trypsin that had already been 
blocked by SBTI; these cultures determined whether trypsin +  SBTI in 
any way modified the response of SC to Con A (group  C). 
dition, cattle and laboratory animals may develop a potent 
anti-tick response characterized by inflammatory cells (e.g., 
neutrophils, mast cells, basophils, eosinophils) present at the 
tick feeding site and the development of specific  cell-mediated 
and humoral immunity (6, 7, 23). This anti-tick response 
may decrease the tick's blood-feeding success and ultimately 
cause rejection of the tick. In contrast to the guinea pig, Trager 
(5) found that such anti-tick immunity developed poorly if 
at all in the white-footed mouse, Peromyscus leucopus, which 
is a natural host for D  variabilis. These observations were in- 
terpreted  (24) to mean that either natural hosts  were im- 
munoincompetent or that in natural hosts, the tick was able 
to evade the host's immune response. However, the mecha- 
nism by which the tick could evade the host immune response 
was not clear. 
Subsequent work by Wikel (25) demonstrated that when 
guinea pigs were infested with D. andersoni, their responses 
to the T cell mitogens Con A and PHA were reduced.  In 
addition, a recent report of Roehrig et al. (12), suggests that 
tick infestation may modify antipathogen responses as well. 
When hamsters were infected with B. burgdorferi (the causa- 
tive agent of Lyme disease) delivered by syringe needle, the 
animals mounted an early and potent antibody response to 
two antigens of the spirochete, OspA and OspB. In contrast, 
when the hamsters were infected by the bite of infected ticks, 
the animals did not have a detectable antibody response to 
OspA and OspB. This result is identical to that seen  in human 
beings that acquire Lyme disease  by tick bite, because humans 
do not develop antibody to OspA and OspB until late in the 
course of infection. Thus, not only are ticks able to circum- 
vent host immunity, but microorganisms that are transmitted 
by ticks may also not elicit an effective immune response. 
All of the observations discussed above may be explained 
by the activity of a potent immunosuppressive factor in tick 
saliva. Many authors have speculated that this factor might 
be PGE2 (2,  3,  14-16). However,  PGE2 is  quite labile in 
vivo; one transit through the pulmonary circulation removes 
>95% of PGE2 activity (26). Thus, it is unlikely that PGE2 
could have been responsible for the immunosuppression ob- 
served, especially given the work of Wikel (25) which indi- 
cated that infestation of guinea pigs with ticks had a long- 
lived, systemic immunosuppressive effect, We show here that 
PGE2 is not the main factor responsible for the immunosup- 
pressive effects of female I. dammini saliva or salivary gland 
lysates. Instead, suppression is primarily mediated by a pro- 
tein of >5,000 mol wt (Figs. 7-9).  Interestingly,  this pro- 
tein may be sex specific; preliminary experiments reveal that 
male salivary glands do not contain an immunosuppressive 
factor. Male Ixodes ticks may not be as dependent upon im- 
munosuppressive factors of their saliva since unlike metas- 
triate Dermacentor or A mblyomma male ticks, male Ixodes do 
not require a bloodmeal even though they do attach and a 
variable proportion will ingest RBC's (27; Telford, S. K., 
III, unpublished  results).  In addition,  male Ixodes do not 
transmit/~ burgdorferi or coinfecting Babesia microti (Telford, 
S. R., III, unpublished  results). Finally, it should be men- 
tioned that salivary gland proteins are also expressed in a sex- 
specific manner in the mosquito, Aedes aegypti. The salivary 
glands of females contain abundant amounts of a protein 
termed D7, but male glands contain little of this protein (28). 
The specific pattern of feeding by each I. dammini instar 
may have driven this tick to develop  mechanisms for preventing 
the development of host anti-tick immunity. Nymphal forms 
of/. dammini feed on and transmit B. burgdorferi to P. leucopus 
(the natural mouse host for the tick) early in the transmis- 
sion season (April to July). Subsequently (July to September), 
larval forms of L  dammini feed on these infected mice and 
acquire the spirochete in the bloodmeal. This seasonal inver- 
sion of feeding activity then forcefully maintains the agent 
of Lyme disease from year to year (29). If on the other hand, 
host anti-tick immunity were to develop, the feeding success 
of the tick (especially larval forms which feed after nymphal 
forms)  and the survival of the spirochete would both be 
jeopardized. Because  the immunosuppressive activities within 
tick saliva may inhibit a host anti-tick response, the mole- 
cules responsible for such activities may have driven the coevo- 
lution of ticks as well as pathogens with their hosts. 
Although Lyme disease is transmitted very efficiently by 
I. dammini,  very few spirochetes appear to be delivered by 
the tick to the site of its bite (30, 31). The cellular infiltrate 
at this site (neutrophils, mast cells, eosinophils) should, but 
would appear  not  to,  offer  a  formidable  barrier  for  the 
spirochete. Therefore, it is possible that the immunosuppressive 
armament within I. dammini saliva is used by the spirochete 
to evade host defenses and to successfully establish infection. 
If tick saliva enhances the infectivity of the pathogens trans- 
mitted by ticks, sensitizing the host against ticks should alter 
disease transmission by ticks. In fact, this is the case since 
1083  Urioste et al. tick-sensitized guinea pigs are refractory to tularemia (32). 
Thus, tick saliva  may enhance the infectivity  of tick-transmitted 
pathogens as has been demonstrated for the saliva of two other 
arthropod vectors:  sand fly saliva enhances the infectivity of 
Leiskmania (33-36) and tick saliva the infectivity of Thogoto 
virus (37). These observations have led to the hypothesis that 
an alternative method for vaccinating against the pathogens 
that blood-sucking arthropod vectors transmit is to vaccinate 
the host against the immunosuppressive factors of the vectors' 
saliva (4). 
Taken together, the observations presented here as well as 
the work of others that is discussed,  suggests that coevolu- 
tion of ticks, tick hosts, and the pathogens that ticks transmit 
may have, in part, been driven by immunosuppressive factors 
in the tick's saliva. That is, ticks that had these immunosup- 
pressive factors may have been more successful at blood feeding, 
and thus reproduction; and pathogens transmitted by these 
ticks may have been more successful at infecting the host, 
and thus, once again, more successful at reproduction. Be- 
cause hard ticks are vectors of a variety of prevalent zoonoses 
in the United States (Lyme disease, Rocky Mountain spotted 
fever, Colorado tick fever, tularemia, babesiosis, and ehrlichi- 
osis, all transmitted via the tick salivary gland), and because 
the efficiency of transmission and the course of  infection may 
be influenced by immunosuppressive molecules present in the 
tick's saliva, further analysis of the pharmacologically/immuno- 
logically active molecules of  vector saliva may serve to broaden 
our basic understanding of disease transmission and may con- 
tribute to public health worldwide. 
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